Ep 109 - Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results

Ep 111 - Ethicon’s Tom O’Brien explains the design – and critical need for - its new surgical stapler

In this episode, Tom O’Brien, Ethicon’s worldwide president of endomechanical, gives a detailed lesson on the design of its Echelon 3000 surgical stapler, from recognizing the huge problem of surgical complications and identifying how to build a stapler that’s more suited to ALL surgeons. The Echelon 3000 is designed with 39% greater jaw aperture and a 27% greater articulation span, as well as software that provides real-time haptic and audible device feedback to help enable surgeons to make critical adjustments during procedures. Executive Editor Life Sciences Chris Newmarker conducts that interview and brings his Newmarker’s Newsmakers hitting upon news from Stryker, Pear Therapeutics, Dexcom and 3M. We also talk about the world’s largest orthopedics companies (find the list here https://www.massdevice.com/10-largest-orthopedic-device-companies-in-the-world-2022/) and the current spate of disappointing earnings reports from medical device companies If you’re interested in learning more about our upcoming DeviceTalks West event, join Editorial Director Tom Salemi on this short webinar. https://event.on24.com/wcc/r/3878353/5BD2F587B74A5106D4FFC61E92BC6354 Subscribe on all major podcast players.

Ep 110 - Camille Chang Gilmore shares Boston Scientific’s successful approach to hitting many DEI goals

In this episode, Camille Chang Gilmore, vice president, human resources and global chief diversity officer, explains why she accepted Boston Scientific CEO Mike Mahoney’s offer to help lead the company’s diversity and inclusion efforts. This company’s work led to the creation of multiple programs promoting equity and combatting racism, earning Boston Scientific multiple awards and recognition from outside the company. She also shares as personal memory that speaks to the success she’s seen. This episode is brought to you by KNF. In this week’s Newmarker’s Newsmakers, Executive Editor Chris Newmarker brings a bounty of big news items from Synchron, Amazon, Intuitive, J&J and iRhythm.

Ep 109 - Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results

In this episode, Boston Scientific CEO Michael Mahoney makes his DeviceTalks Weekly Podcast debut. In this jam-packed interview, Mahoney walks us through the cultural changes Boston Scientific has made since he joined the company a decade ago. He explains how restructuring has helped to identify leaders rather than managers. How Boston Scientific encourages people to take risks. Where does Boston Scientific see growth in markets and technologies. (We ask if Boston needs a surgical robotics platform.) Mahoney also explains how Boston Scientific knows when to let an opportunity go. We talk about experiences from his own career that others can take us lessons. Mahoney also explains what co-founder Pete Nicholas, who passed away recently, meant to the company, and what Boston Scientific will look like in five years. How will Boston Scientific move forward if the economy weakens. This episode is sponsored by PSN Labs. Executive editor Chris Newmarker brings his #NewmarkersNewsmakers – Cardinal Health, Acutus Medical, Medtronic and Boston Scientific. We also walk through a list of Medical Device companies are responding to the SCOTUS’s overturning Roe v. Wade and what this might mean for healthcare care data collection.

Ep 108 - How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market

In this week’s episode, Cala Health CEO Renee Ryan joins us in the Newmarker’s Newsmaker’s booth to share her insights on the news of the week including an interesting meeting with Mike Mahoney before he become CEO of Boston Scientific. Ryan also shares details on the growing success of the Cala Trio, a device worn on the wrist to help control essential tremors. We dive deep into Cala’s story, talking with Deanna Harshbarger, vice president, product, and Doug Biehn, chief commercial officer. This episode is sponsored by AcuityMD. Executive Editor Chris Newmarker returns with his Newmarker’s Newsmakers – GE Healthcare, Boston Scientific, Ekso Bionic, Medtronic and Abbott.

Ep 107 - Can Moon Surgical fill critical role in the OR? Analyst Matson’s take on J&J, Medtronic and more

In this episode, Michael Matson, analyst at Needham, explains his thoughts behind a possible J&J acquisition of Boston Scientific. He also explains why he downgraded Medtronic and his take on supply chain issues. The rest of the episode will focus on Moon Surgical, which recently closed on a $31 million Series A to build a new robot that could lend critical assistance to surgeons. We speak with CEO Ann Osdoit about the company’s plans as well as investor and advisor Steve Oesterle, formerly of Medtronic. Oesterle also gives his assessment of the broader medical device-technology convergence including some fascinating forecasts for Verily. This episode is sponsored by KNF. Also hear more information about our upcoming DeviceTalks Tuesdays session and DeviceTalks West in-person meeting.